Glucosamine hydrochloride
CAS 66-84-2
Glucosamine hydrochloride (CAS 66-84-2) is a pharmaceutical compound with 0 bioactivity targets and 81 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Glucosamine hydrochloride is linked to DTXSID5037236 in DSSTox identifiers.
View industrial chemical data →Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| GLUCOSAMINE HYDROCHLORIDE | 236608 | SU | MTHSPL |
| glucosamine hydrochloride | 236608 | PIN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Glucosamine hydrochloride used for in pharmaceutical contexts?
Glucosamine hydrochloride (CAS 66-84-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Glucosamine hydrochloride?
Glucosamine hydrochloride has 81 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Dermatitis atopic, Neoplasm, Balance disorder, Bladder disorder, Blood calcium decreased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Glucosamine hydrochloride also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Glucosamine HCl with EU status "permitted".
What clinical phase is Glucosamine hydrochloride in?
No phase 1-4 clinical development badge is rendered for Glucosamine hydrochloride because the matched compound identifier rows do not contain a max-phase value.